Aala Jaberi, MB, BCh, BAO

Assistant Professor, Medicine

Aala Jaberi


Dr. Jaberi obtained her medical degree from Royal College of Surgeons in Ireland. She completed her initial clinical training in internal medicine in Ireland. She became a member of Royal College of Physicians in Ireland following the successful completion of her training and examinations. Prior to joining Boston University, she completed a research fellowship in the laboratory of Dr. Andrey Cybulsky at McGill University. As a research fellow at McGill, Dr. Jaberi examined the cellular pathways involved in kidney development and cellular kidney injury. In particular, Dr. Jaberi focused on understanding the molecular events that occur during ischemic-reperfusion injury and podocyte injury. Following her training in laboratory research, Dr. Jaberi pursued a clinical and research nephrology fellowship at Boston University. An accomplished educator and clinician, Dr. Jaberi was the recipient of the 2020 Sub-specialty Teaching Award from BMC’s Internal Medicine Residency program and the 2021 Clinical Excellence Award from the Boston University Medical Group. Dr. Jaberi serves as the Medical Director of Boston Medical Center’s Acute Dialysis Program.


  • Royal College of Surgeons in Ireland, MBBCh


  • Published on 11/27/2023

    Trivin-Avillach C, Jaberi A, Henderson JM, Beck LH, Francis J. Eculizumab Use in Scleroderma Renal Crisis With Thrombotic Microangiopathy: A Case Report. Kidney Med. 2024 Jan; 6(1):100753. PMID: 38225975.

    Read at: PubMed
  • Published on 1/1/2022

    Kamel MH, Jaberi A, Gordon CE, Beck LH, Francis J. The Complement System in the Modern Era of Kidney Transplantation: Mechanisms of Injury and Targeted Therapies. Semin Nephrol. 2022 Jan; 42(1):14-28. PMID: 35618392.

    Read at: PubMed
  • Published on 9/10/2020

    Driscoll D, Bleecker G, Francis J, Jaberi A. Acute Hemodialysis for Treatment of Severe Ethanol Intoxication. Kidney Med. 2020 Nov-Dec; 2(6):793-796. PMID: 33319202.

    Read at: PubMed
  • Published on 10/9/2019

    Angel-Korman A, Jaberi A, Sanchorawala V, Havasi A. The utility of repeat kidney biopsy in systemic immunoglobulin light chain amyloidosis. Amyloid. 2020 Mar; 27(1):17-24. PMID: 31595786.

    Read at: PubMed
  • Published on 8/19/2017

    Al-Rabadi L, Quillen K, Shashar M, Al Marji C, Jaberi A, Chitalia V, Henderson J, Salant D, Beck LH. Concurrent Presentation of Thrombotic Thrombocytopenic Purpura and Membranous Nephropathy. Kidney Int Rep. 2018 Mar; 3(2):476-481. PMID: 29725652.

    Read at: PubMed
  • Published on 10/1/2016

    Jaberi A, Seth B, Steenkamp D, Alexanian S, Borkan SC. Sodium-Glucose Cotransporter 2 Inhibitors and Euglycemic Diabetic Ketoacidosis: Metabolic Acidosis With a Twist. Clin Diabetes. 2016 Oct; 34(4):214-216. PMID: 27766015.

    Read at: PubMed
  • Published on 6/18/2015

    Jaberi A, Hooker E, Guillemette J, Papillon J, Kristof AS, Cybulsky AV. Identification of Tpr and a-actinin-4 as two novel SLK-interacting proteins. Biochim Biophys Acta. 2015 Oct; 1853(10 Pt A):2539-52. PMID: 26094769.

    Read at: PubMed
  • Published on 4/24/2012

    Kitzler TM, Jaberi A, Sendlhofer G, Rehak P, Binder C, Petnehazy E, Stacher R, Kotanko P. Efficacy of vitamin E and N-acetylcysteine in the prevention of contrast induced kidney injury in patients with chronic kidney disease: a double blind, randomized controlled trial. Wien Klin Wochenschr. 2012 May; 124(9-10):312-9. PMID: 22527829.

    Read at: PubMed
  • Published on 12/27/2011

    Luhovy AY, Jaberi A, Papillon J, Guillemette J, Cybulsky AV. Regulation of the Ste20-like kinase, SLK: involvement of activation segment phosphorylation. J Biol Chem. 2012 Feb 17; 287(8):5446-58. PMID: 22203681.

    Read at: PubMed

View all profiles